Vinícius Augusto Simão

Prof. Dr. Vinícius Augusto Simão

Instituto de Biociências - Unesp -Botucatu, Botucatu, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
FSFabio Seiva
Fabio Seiva
ANAdriana Alonso Novais
Adriana Alonso Novais
Vinícius Augusto SimãoVinícius Augusto Simão
Vinícius Augusto Simão
VGVirna Margarita Martín Giménez
Virna Margarita Martín Giménez
Russel ReiterRussel Reiter
Russel Reiter
The use of nanosized particles has emerged to facilitate selective applications in medicine. Drug-delivery systems represent novel opportunities to provide stricter, focused, and fine-tuned therapy, enhancing the therapeutic efficacy of chemical agents at the molecular level while reducing their toxic effects. Melatonin (N-acetyl-5-methoxytriptamine) is a small indoleamine secreted essentially by the pineal gland during darkness, but also produced by most cells in a non-circadian manner from which it is not released into the blood. Although the therapeutic promise of melatonin is indisputable, aspects regarding optimal dosage, biotransformation and metabolism, route and time of administration, and targeted therapy remain to be examined for proper treatment results. Recently, prolonged release of melatonin has shown greater efficacy and safety when combined with a nanostructured formulation. This review summarizes the role of melatonin incorporated into different nanocarriers (e.g., lipid-based vesicles, polymeric vesicles, non-ionic surfactant-based vesicles, charge carriers in graphene, electro spun nanofibers, silica-based carriers, metallic and non-metallic nanocomposites) as drug delivery system platforms or multilevel determinations in various in vivo and in vitro experimental conditions. Melatonin incorporated into nanosized materials exhibits superior effectiveness in multiple diseases and pathological processes than does free melatonin; thus, such information has functional significance for clinical intervention.

12 May 2023 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
Vinícius Augusto SimãoVinícius Augusto Simão
Vinícius Augusto Simão
HBHeloisa Brand
Heloisa Brand
RSRoseli Nunes da Silveira-Antunes
Roseli Nunes da Silveira-Antunes
JFJosianne Thomazini Fukasawa
Josianne Thomazini Fukasawa
JLJaci Leme
Jaci Leme
JRJoão Tadeu Ribeiro-Paes
João Tadeu Ribeiro-Paes

17 April 2014 in Birth Defects Research Part B: Developmental and Reproductive Toxicology
Verified
Journal Article
Closed access
PDF file
LBLarissa Berloffa Belardin
Larissa Berloffa Belardin
Vinícius Augusto SimãoVinícius Augusto Simão
Vinícius Augusto Simão
GLGabriel Adan Araújo Leite
Gabriel Adan Araújo Leite
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
ICIsabel Cristina Cherici Camargo
Isabel Cristina Cherici Camargo

1 October 2015 in International Journal of Experimental Pathology
Verified
Journal Article
Closed access
PDF file
Vinícius Augusto SimãoVinícius Augusto Simão
Vinícius Augusto Simão
LBLarissa Berloffa Belardin
Larissa Berloffa Belardin
GLGabriel Adan Araújo Leite
Gabriel Adan Araújo Leite
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
ICIsabel Cristina Cherici Camargo
Isabel Cristina Cherici Camargo

Verified
Journal Article
Open access
PDF file
RJRubens Paula Junior
Rubens Paula Junior
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
Vinícius Augusto SimãoVinícius Augusto Simão
Vinícius Augusto Simão
NSNathália Martins Sonehara
Nathália Martins Sonehara
Roger ChammasRoger Chammas
Roger Chammas
Debora Aparecida Pires Campos ZuccariDebora Aparecida Pires Campos Zuccari
Debora Aparecida Pires Campos Zuccari
Metabolic dysregulation as a reflection of specific metabolite production and its utilization is a common feature of many human neoplasms. Melatonin, an indoleamine that is highly available during darkness, has a variety of metabolic functions in solid tumors. Because plasma metabolites undergo circadian changes, we investigated the role of melatonin on the profile of amino acids (AAs), biogenic amines, carnitines, sphingolipids, and hexoses present in the plasma of mice bearing xenograft triple negative breast cancer (MDA-MB-231 cells) over 24 h. Plasma concentrations of nine AAs were reduced by melatonin, especially during the light phase, with a profile closer to that of non-breast cancer (BC) animals. With respect to acylcarnitine levels, melatonin reduced 12 out of 24 molecules in BC-bearing animals compared to their controls, especially at 06:00 h and 15:00 h. Importantly, melatonin reduced the concentrations of asymmetric dimethylarginine, carnosine, histamine, kynurenine, methionine sulfoxide, putrescine, spermidine, spermine, and symmetric dimethylarginine, which are associated with the BC metabolite sets. Melatonin also led to reduced levels of sphingomyelins and hexoses, which showed distinct daily variations over 24 h. These results highlight the role of melatonin in controlling the levels of plasma metabolites in human BC xenografts, which may impact cancer bioenergetics, in addition to emphasizing the need for a more accurate examination of its metabolomic changes at different time points.

1 November 2016 in Reproduction
Verified
Journal Article
Open access
PDF file
Vinícius Augusto SimãoVinícius Augusto Simão
Vinícius Augusto Simão
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
ICIsabel Cristina Cherici Camargo
Isabel Cristina Cherici Camargo
This study evaluated for the first time the effects of different doses of the anabolic steroid nandrolone decanoate (ND) on the expression of ovarian steroid receptors (AR, ER-α (ESR1) and ER-β (ESR2)) and related sex hormones after treatment and recovery periods in adult rats. The animals were injected subcutaneously with doses of ND (1.87, 3.75, 7.5 or 15 mg/kg b.w.) or mineral oil (control group) for 15 days, and the experimental groups were divided into three periods of evaluation: (a) ND treatment for 15 days, (b) ND treatment and recovery for a period of 30 days and (c) ND treatment and recovery for a period of 60 days. Estrous cycle was monitored daily. At the end of each period, rats were killed for collection of blood and ovaries. Persistent diestrus occurred in all rats during ND treatment and after 30-day recovery. The highest dose of ND was able to maintain all rats arrested at diestrus until 60-day recovery. The expression of steroid receptors varied in a dose- and period-dependent manner, having a more pronounced response with the dose of 15 mg ND/kg. ND treatment increased serum levels of testosterone, 17β-estradiol and dihydrotestosterone, especially at the highest doses of 7.5 and 15 mg ND/kg. No change was observed in the levels of follicle-stimulating hormone (FSH), whereas levels of the luteinizing hormone (LH) varied according to the dose and period. In conclusion, the ovarian sex steroid receptors and sex hormones were restored only at lower doses of ND and after a longer period of recovery.